Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
Chuang S.-E.
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 1 到 20 筆資料,總共 36 筆
下一頁 >
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2013
Aspirin antagonizes the cytotoxic effect of methotrexate in lung cancer cells
Yan K.-H.; Lee L.-M.; Hsieh M.-C.; Yan M.-D.; Yao C.-J.; Chang P.-Y.; Chen T.-L.; Chang H.-Y.; ANN-LII CHENG
; Lai G.-M.; Chuang S.-E.
Oncology Reports
18
19
2002
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells
Chuang S.-E.; Yeh P.-Y.; YEN-SHEN LU
; Lai G.-M.; Liao C.-M.; Gao M.; ANN-LII CHENG
Biochemical Pharmacology
161
138
1998
Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity
Kuo M.-L.; Shen S.-C.; CHIH-HSIN YANG
; Chuang S.-E.; ANN-LII CHENG
; Huang T.-S.
Oncogene
39
35
1998
Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma
ANN-LII CHENG
; KUN-HUEI YEH
; Fine R.L.; Chuang S.-E.; Yang C.-H.; Wang L.-H.; DING-SHINN CHEN
Hepato-Gastroenterology
41
33
2008
Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway
Dai H.-Y.; Hong C.-C.; Liang S.-C.; Yan M.-D.; Lai G.-M.; ANN-LII CHENG
; Chuang S.-E.
Molecular Carcinogenesis
38
35
1996
Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma
ANN-LII CHENG
; YAO-CHANG CHEN
; KUN-HUEI YEH
; Chuang S.-E.; Chen B.-R.; DING-SHINN CHEN
Cancer
37
2007
CTGF enhances the motility of breast cancer cells via an integrin-αvβ3-ERK1/2-dependent S100A4-upregulated pathway
PO-HUANG LEE
; CHIUNG-NIEN CHEN
; KUO-TAI HUA
; Su J.-L.; Hong C.-C.; Chuang S.-E.; Chen M.-W.; Hua K.-T.; Wu Y.-L.; Cha S.-T.; Babu M.S.; KING-JEN CHANG
; Kuo M.-L.
Journal of Cell Science
131
127
2006
Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone
Yao C.-J.; Lai G.-M.; Chan C.-F.; ANN-LII CHENG
; Yang Y.-Y.; Chuang S.-E.
International Journal of Cancer
67
67
2014
erratum: Oxidative stress enhances AXL-mediated cell migration through AKT1/Rac1-dependent mechanism (Free Radical Biology and Medicine (2013) 65 (1246-1256))
Huang J.-S.; Cho C.-Y.; Hong C.-C.; Yan M.-D.; Hsieh M.-C.; Lay J.-D.; Lai G.-M.; ANN-LII CHENG
; Chuang S.-E.
Free Radical Biology and Medicine
0
0
1997
Factors associated with the therapeutic efficacy of retinoic acids on malignant lymphomas
ANN-LII CHENG
; Chuang S.-E.; Su I.-J.
Journal of the Formosan Medical Association
10
9
2006
Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa
YEN-SHEN LU
; Yeh P.-Y.; Chuang S.-E.; Gao M.; Kuo M.-L.; ANN-LII CHENG
Journal of Endocrinology
23
21
1995
Growth of E.coli at low temperature dramatically increases the transformation frequency by electroporation
Chuang S.-E.; ANN-LII CHENG
; Chao C.-C.
Nucleic Acids Research
20
19
2003
Hepatitis B virus X protein activates a survival signaling by linking Src to phosphatidylinositol 3-kinase
Shih W.-L.; Kuo M.-L.; Chuang S.-E.; ANN-LII CHENG
; SHIN-LIAN DOONG
Journal of Biological Chemistry
52
49
2000
Hepatitis b virus x protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway
Shih W.-L.; Kuo M.-L.; Chuang S.-E.; ANN-LII CHENG
; SHIN-LIAN DOONG
Journal of Biological Chemistry
174
163
2005
Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas
Yan M.-D.; Hong C.-C.; Lai G.-M.; ANN-LII CHENG
; Lin Y.-W.; Chuang S.-E.
Human Molecular Genetics
84
80
2002
Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NFκB activation
Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH
; Song Y.C.; Ea C.-K.; ANN-LII CHENG
Biochemical Pharmacology
130
128
2002
Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin
CHIH-HUNG HSU
; Hergenhahn M.; Chuang S.-E.; Yeh P.-Y.; Wu T.-C.; Gao M.; ANN-LII CHENG
Anticancer Research
15
13
2000
Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats
Chuang S.-E.; ANN-LII CHENG
; Lin J.-K.; Kuo M.-L.
Food and Chemical Toxicology
181
151
1998
Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen
ANN-LII CHENG
; Chuang S.-E.; Fine R.L.; KUN-HUEI YEH
; Liao C.-M.; Lay J.-D.; Chen D.-S.
Biochemical Pharmacology
69
65
2004
Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells
YEONG-SHIAU PU
; Hour T.-C.; Chuang S.-E.; ANN-LII CHENG
; Lai M.-K.; Kuo M.-L.
Prostate
70
71